Delivery Order SPE2DB20D9329-SPE2DB24FZK76

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,844.60 firm fixed-price delivery order is for the supply of Alfuzosin Hydrochloride, a medication, with a period of performance through May 23, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,062.77 firm fixed-price delivery order is for the supply of Alfuzosin HCl ER 10 mg tablets, with a completion date of May 9, 2024. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,449.52, is for the delivery of Alfuzosin Hydrochloride Extended-Release 10 mg tablets. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,771.28 contract is for the delivery of a specific pharmaceutical item, Alfuzosin HCl ER 10 mg Tablets, to support the medical supply needs of Department of Defense (DoD) healthcare facilities. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) vehicle held by DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,844.60 contract is for the delivery of Alfuzosin Hydrochloride, a pharmaceutical product, with a completion date of March 21, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $1,097.28 for the supply of 4559319402 ALFUZOSIN HCL ER 10 MG TABLET 100S. The contract was awarded by the Defense Logistics Agency (DLA) on November 14, 2022, with a completion date of November 15, 2022. DMS Pharmaceutical Group is a key supplier of pharmaceuticals and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA), providing a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Alfuzosin Hydrochlo medical supplies, with a ceiling value of $5,844.60 and an ultimate completion date of July 18, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic...
The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $100,000 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the supply of 100 boxes containing 10 mg tablets of alfuzosin hydrochloride extended release. DMS Pharmaceutical Group will deliver the pharmaceutical products to a location in Park Ridge, Illinois by August 29, 2023 under the terms of the order. No set aside designation or subcontracting details were provided in...
DMS Pharmaceutical Group Inc. was awarded a firm fixed price delivery order for $8,865 by the Defense Logistics Agency Troop Support Medical to provide 8503583083 ALFUZOSIN HYDROCHLO. The place of performance is Park Ridge, Illinois. The completion date is September 27, 2016. No set-aside designation was used for this award. DMS Pharmaceutical Group Inc. is a woman-owned small business and woman-owned business that holds additional contracts and an indefinite delivery contract vehicle with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,193.95 firm-fixed-price delivery order is for the supply of 90-count bottles of the prescription medication Alfuzosin HCl Extended-Release 10 mg Tablets. The contract has an ultimate completion date of May 14, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB20D9329
    Indefinite Delivery Contract
  • SPE2DB20D9329-SPE2DB24FZK76
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,217.16 firm fixed-price delivery order is for the supply of Alfuzosin Hydrochloride Extended-Release 10 mg Tablets in 120-count bottles.

The contract is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group provides both routine and critical medications through this IDC, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain. The contract does not have a set-aside designation.

Generated 1/9/25, 9:23 AM